COVID-19 is forcing European laboratories to re-think where they test patients. Some are working with authorities to set up new ‘drive-through’ testing points, while others have closed more than half of their drawing points.
We talk to senior banking figures about the approaching sale of French hospital group Elsan by CVC Capital Partners. One reckons a quiet "deal within the French establishment" is likely while another says the obvious strategic buyer should not be ruled out.
In the second of our two-part deep dive into how COVID-19 is hitting healthcare markets across EMEA, we ask how hospitals are coping with spiralling staff sickness and a flood of patients, and whether the care and dialysis sectors can stay afloat given the risk the virus poses to their most vulnerable patients.
Hospitals and insurers have been looking for consolidated digital health platforms ever since they grew tired of 'pilotitus' from a fragmented market. But what if they could become a central administrator to an "ecosystem" where thousands of start-ups become third-party plug-ins? Biesdorf is convinced that this is about to happen in Germany.
Temporary agencies are expensive. Hiring a doctor through one in the UK can cost the NHS around €170 per shift and in Germany, the bill for a nurse comes in at anywhere between €70-€140. A handful of start-ups across Europe are deploying solutions to disrupt agencies and breakdown workforce silos. HBI looks at three - in the UK, France and Germany - to assess how the market is changing.
CVC Capital Partners is talking to advisors about sale options for Elsan, the large French hospital group it has owned since 2014, according to reports. We speculate on potential buyers.
French hospital group Elsan has acquired its third hospital in Morocco. Head of international development Emile Dinet talks HBI through its strategy in Africa's fifth-largest economy, which only recently allowed institutional investment into its health sector.
French private equity firm Ardian has acquired a majority stake in Santé Cie, the parent company of medicalised homecare specialists Elivie and Asdia. We discuss Santé Cie's plans and the wider market with an expert in the respiratory sector from advisors Candesic.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.